HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.

Abstract
Active targeting of nanostructures containing chemotherapeutic agents can improve cancer treatment. Here, a three-way junction pocket DNA nanostructure was developed for efficient doxorubicin (Dox) delivery into cancer cells. The three-way junction pocket DNA nanostructure is composed of three strands of AS1411 aptamer as both a therapeutic aptamer and nucleolin target, the potential biomarker of prostate (PC-3 cells) and breast (4T1 cells) cancers. The properties of the Dox-loaded three-way junction pocket DNA nanostructure were characterized and verified to have several advantages, including high serum stability and a pH-responsive property. Cellular uptake studies showed that the Dox-loaded DNA nanostructure was preferably internalized into target cancer cells (PC-3 and 4T1 cells). MTT cell viability assay demonstrated that the Dox-loaded DNA nanostructure had significantly higher cytotoxicity for PC-3 and 4T1 cells compared to that of nontarget cells (CHO cells, Chinese hamster ovary cell). The in vivo antitumor effect showed that the Dox-loaded DNA nanostructure was more effective in prohibition of the tumor growth compared to free Dox. These findings showed that the Dox-loaded three-way junction pocket DNA nanostructure could significantly reduce the cytotoxic effects of Dox against nontarget cells.
AuthorsSeyed Mohammad Taghdisi, Noor Mohammad Danesh, Mohammad Ramezani, Rezvan Yazdian-Robati, Khalil Abnous
JournalMolecular pharmaceutics (Mol Pharm) Vol. 15 Issue 5 Pg. 1972-1978 (05 07 2018) ISSN: 1543-8392 [Electronic] United States
PMID29669200 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • AGRO 100
  • Aptamers, Nucleotide
  • DNA Adducts
  • Drug Carriers
  • Oligodeoxyribonucleotides
  • Phosphoproteins
  • RNA-Binding Proteins
  • doxorubicin-DNA
  • Doxorubicin
  • DNA
Topics
  • Animals
  • Aptamers, Nucleotide (chemistry)
  • Breast (chemistry)
  • Breast Neoplasms (drug therapy)
  • CHO Cells
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Cricetulus
  • DNA (chemistry)
  • DNA Adducts (chemistry)
  • Doxorubicin (chemistry, pharmacology)
  • Drug Carriers (chemistry)
  • Drug Delivery Systems (methods)
  • Female
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Nanoparticles (chemistry)
  • Nanostructures (chemistry)
  • Oligodeoxyribonucleotides (chemistry)
  • Phosphoproteins (chemistry)
  • Prostatic Neoplasms (drug therapy)
  • RNA-Binding Proteins (chemistry)
  • Nucleolin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: